Cogent Biosciences Inc.

NASDAQ: COGT · Real-Time Price · USD
11.88
0.17 (1.45%)
At close: Aug 15, 2025, 3:59 PM
11.89
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT

Cogent Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
4.4M 3.59M 5.88M 147K
Gross Profit
-4.4M -3.59M -5.88M -147K
Operating Income
-275.94M -208.13M -147.84M -75.55M
Interest Income
18.09M 13.08M 3.99M 467K
Pretax Income
-255.86M -192.41M -140.24M -72.27M
Net Income
-255.86M -192.41M -132.64M -71.81M
Selling & General & Admin
43.28M 34.38M 26.21M 19.64M
Research & Development
232.66M 170.17M 121.63M 55.91M
Other Expenses
n/a n/a 3.61M n/a
Operating Expenses
275.94M 208.13M 147.84M 75.55M
Interest Expense
n/a n/a 3.99M n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
275.94M 208.13M 147.84M 75.55M
Income Tax Expense
n/a n/a n/a -467K
Shares Outstanding (Basic)
103.86M 79.66M 58.74M 38.73M
Shares Outstanding (Diluted)
103.86M 79.66M 58.74M 38.73M
EPS (Basic)
-2.46 -2.42 -2.26 -1.85
EPS (Diluted)
-2.46 -2.42 -2.26 -1.85
EBITDA
-275.94M -205.86M -134.36M -75.4M
EBIT
-275.94M -208.13M -147.84M -75.55M
Depreciation & Amortization
2.45M 2.27M 5.88M 147K